Fidelity Investments’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.7K | Sell |
|
|||||
|
2025
Q1 | $32.1K | Sell |
|
|||||
|
2024
Q4 | $213K | Sell |
|
|||||
|
2024
Q3 | $293K | Buy |
|
|||||
|
2024
Q2 | $57.4K | Buy |
|
|||||
|
2024
Q1 | $48.5K | Sell |
|
|||||
|
2023
Q4 | $73.2K | Sell |
|
|||||
|
2023
Q3 | $68.9K | Buy |
|
|||||
|
2023
Q2 | $5.21K | Buy |
|
|||||
|
2023
Q1 | $4.2K | Hold |
|
|||||
|
2022
Q4 | $4.03K | Hold |
|
|||||
|
2022
Q3 | $4K | Sell |
|
|||||
|
2022
Q2 | $4K | Buy |
|
|||||
|
2022
Q1 | $3K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $727K | Hold |
|
|||||
|
2021
Q1 | $927K | Hold |
|
|||||
|
2020
Q4 | $858K | Sell |
|
|||||
|
2020
Q3 | $1.15M | Sell |
|
|||||
|
2020
Q2 | $5.94M | Sell |
|
|||||
|
2020
Q1 | $5.61M | Hold |
|
|||||
|
2019
Q4 | $10.5M | Sell |
|
|||||
|
2019
Q3 | $14M | Hold |
|
|||||
|
2019
Q2 | $21.1M | Hold |
|
|||||
|
2019
Q1 | $21.7M | Buy |
|
|||||
|
2018
Q4 | $23.9M | Hold |
|
|||||
|
2018
Q3 | $26.3M | Sell |
|
|||||
|
2018
Q2 | $35.2M | Sell |
|
|||||
|
2018
Q1 | $43M | Buy |
|
|||||
|
2017
Q4 | $25.7M | Sell |
|
|||||
|
2017
Q3 | $24.2M | Hold |
|
|||||
|
2017
Q2 | $13.9M | Buy |
|